Nutritional Growth Solutions Ltd (NGS)
20mins delayed
Movement
1 Year Return
Nutritional Growth Solutions Ltd Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $13.77 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
NGS Statistics
26 November
1,830 / 2,244
ASX Size Rank
1yr Return
vs Sector (1yr)
+3.35%
vs ASX 200 (1yr)
+8.05%
$13.77 million
Market Cap
Share Issue
43.03 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
26 November
N/A
PE Ratio
EPS ($)
-
Earnings Yield
-
NTA ($)
-
0.00%
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Nutritional Growth Solutions Ltd (NGS) is a global nutritional health company focused on the well-being of children. NGS develops, produces and sells clinically tested nutritional supplement formulae for children following 20 years of medical research into paediatric nutrition at Schneider Children's Medical Centre, Israel's paediatric hospital.
Upcoming Calendar
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Announcements provided by
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
NGS is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Ms Liron Fendell | Chief Executive Officer, Managing Director | Oct 2020 |
|
| Dr Kinneret Livnat Savitzky | Non-Executive Director | Oct 2020 |
|
| Mr Brian Willoughby Leedman | Non-Executive Chairman, Non-Executive Director | Sep 2020 |
|
| Dr Anton Uvarov | Non-Executive Director | Oct 2020 |
|
| Professor Raanan Shamir | Chief Medical Officer, Executive Director | Jan 2014 |
|
| Mr Amir Zaidman | Non-Executive Director | Oct 2020 |
|
Director Transactions
NGS directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
There are no director transactions for code NGS in our database.
Shareholder Distribution
Shareholder Distribution data is unavailable.
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| MOR Research Applications Ltd | 12,604,790 | 13.31% |
| Ms Hadassa Bymel | 8,098,652 | 8.55% |
| Prof Phillip Moshe | 5,028,720 | 5.31% |
| Moshe Cohen | 4,532,143 | 4.79% |
| Prof Raanan Shamir | 4,465,470 | 4.71% |
| Prof Lazar Liora | 3,151,184 | 3.33% |
| Dr Michal Gavan | 3,151,184 | 3.33% |
| ARQ Capital Pty Ltd(Nitsche Family A/C) | 1,759,821 | 1.86% |
| Impact Equities Pty Ltd | 1,693,750 | 1.79% |
| Ms Yulia Uvarova (Techinvest Nominees A/C) | 1,689,290 | 1.78% |
| Brian And Natasha Leedman | 1,500,000 | 1.58% |
| Mr Loh Kok Wah | 982,143 | 1.04% |
| Papillon Holdings Pty Ltd (The Vml No 1 A/C) | 946,875 | 1.00% |
| Edwin Edward & Allison Bulseco (Kc Bulseco Family A/C) | 821,875 | 0.87% |
| Retzos Executive Pty Ltd (Retzos Executive S/Fund A/C) | 816,913 | 0.86% |
| Lachlan 11 Holdings Pty Ltd (Reid Family A/C) | 800,000 | 0.84% |
| Kava Investments Pty Ltd (Rapid Trading A/C) | 750,000 | 0.79% |
| Ms Kathryn Macdonald & Mr Christopher Stewart Macdonald (Macdonald Super Fund A/C) | 750,000 | 0.79% |
| Flinders Medical Centre Foundation | 674,995 | 0.71% |
| Altor Capital Managementpty Ltd(Altor Alpha Fund A/C) | 657,143 | 0.69% |
| Mrs Elena Tsvetnenko (Yuri And Elena A/C) | 640,000 | 0.68% |
| Mr Narinder Singh Sudagar Singh (Sidhu A/C) | 608,929 | 0.64% |
| All other shareholders | 40.75 % | |
The Top 20 Shareholders of NGS hold 59.25% of shares on issue.
NGS Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
NGS Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: NGS develops, produces and sells clinically tested nutritional supplement formulae or children.
Incorporated: --
4 Berkovich St
Tel Aviv Israel 6423806
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.